Genotyping cell-free DNA and circulating tumor cells can provide a useful measure of cancer treatment response up to 16 weeks prior to standard clinical measures, according to a study from a group at the Dana-Farber Cancer Institute.
Researchers from Northwestern University and the University of Chicago have demonstrated in a new study that droplet-based digital PCR offers the ability to detect BCR-ABL1 fusion transcripts with a lower limit of detection and quantification than currently used quantitative PCR
Researchers from the Fred Hutchinson Cancer Research Center have developed a droplet digital PCR assay to precisely enumerate a class of T-cells called tumor-infiltrating lymphocytes (TILs) from cancer tissue, and used the method to demonstrate that the presence and quantity of t
Bio-Rad Laboratories said last week that sales in its Life Science segment, which contains the company's PCR and digital PCR products, dropped 3 percent year over year and 1 percent on a currency-neutral basis.
In a study published this month, Bio-Rad researchers have demonstrated the capability of the company's new droplet digital PCR system using DNA-binding dyes with comparable results to TaqMan and that it's possible to use this new dye-based approach for the quantification of multi
Genetic ID this week announced the addition of digital PCR technology to its portfolio of DNA-based testing technologies, for quantification of genetically modified organisms in highly processed products.